Primary hyperaldosteronism among Chinese hypertensive patients: How are we doing in a local district in Hong Kong

Hong Kong Medical Journal

Volumn 18, Issue 3, 2012, Pages 193-200

  Sy, W M ^a   Fu, S N ^a   Luk, W ^a   Wong, Carlos K H ^b   Fung, L M ^c  

^a Kowloon West Cluster ^*  (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Caritas Medical Centre Hong Kong   (Hong Kong)

Author keywords

Adrenal cortex neoplasms; Aldosterone; Hyperaldosteronism; Hypertension; Prevalence

Indexed keywords

ALDOSTERONE; AMILORIDE; ANTIHYPERTENSIVE AGENT; RENIN; SPIRONOLACTONE;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HONG KONG; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONSET AGE; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; RETROSPECTIVE STUDY; TREATMENT REFUSAL;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HONG KONG; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84862533364     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Collaborative Project of Department of Health and Department of Community Medicine, University of Hong Kong. Population Health survey 2003/2004. Centre for Health Protection website: http://www.chp.gov.hk/files/pdf/full_report_on_population_health_survey_2003_2004_en_20051024.pdf. Accessed Dec 2011.
2. Lo CY, Lam LK, Lam TP, et al. Hong Kong Morbidity Survey 2007-2008. Hong Kong Pract 2010;32:18-26.
3. Legislative Council Panel on Health Services Information Note on Services of Public Out-patient Clinics; LC Paper No. CB(2)729/10-11(07). Legco website: http://www.legco.gov.hk/yr10-11/english/panels/hs/papers/hs0110cb2-729-7-e.pdf. Accessed Dec 2011.
4. Lau GS, Chan JC, Chu PL, Tse DC, Critchley JA. Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong. Ann Pharmacother 1996;30:232-7.
5. Sham Shui Po Healthy and Safety website: http://www.safecommunity.hk/ssp/e_setting2.html. Accessed Dec 2011.
6. Onusko E. Diagnosing secondary hypertension. Am Fam Physician 2003;67:67-74.
7. Chan WB. Endocrine hypertension-strategy for screening and workup. Hong Kong Med Diary 2006;11:12-5.
8. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-8.
9. Wolak T, Hazkani I, Friger M, Paran E. Target organ damage in hyperaldosteronism versus essential hypertension-the Beer Sheba experience [in Hebrew]. Harefuah 2010;149:161- 5,194.
10. Ganguly A. Primary aldosteronism. N Engl J Med 1998;339:1828-34.
11. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004;89:1045-50.
12. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999;353:40.
13. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48:2293-300.
14. Young WF Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 2003;144:2208-13.
15. Strauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky J Jr. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003;17:349-52.
16. Mosso L, Carvajal C, González A, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003;42:161-5.
17. Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patient with medication? Endocr J 2007;54:487-95.
18. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000;85:2854-9.
19. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-81.
20. Tiu SC, Choi CH, Shek CC, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005;90:72-8.
21. Lo CY, Tam PC, Kung AW, Lam KS, Wong J. Primary aldosteronism. Results of surgical treatment. Ann Surg 1996;224:125-30.
22. Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002;89:1587-93.
23. Bethesda MD. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2004. National Heart Lung and Blood Institute website: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm. Accessed Dec 2011.